Conmed reports Q3 adjusted EPS 90c, consensus 83c

Reports Q3 revenue $304.6M, consensus $301.22M. “The third quarter saw our team drive double-digit revenue and earnings growth amid healthy end markets,” commented Curt R. Hartman, CONMED’s Chair of the Board, President, and Chief Executive Officer. “I’m proud of what we’ve accomplished year to date in 2023, particularly that the team has been able to drive above-market revenue growth in both businesses.”